Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,214 total articles
AGA Precision Systems, a subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB), has signed a long-term agreement to supply mission-critical aerospace and defense components to Turbo-Jet Products. The agreement spans an initial five years with options for renewal, reinforcing AGA's strategic role in the aerospace and defense supply chain, supported by its…
InflaRx N.V., a biopharmaceutical company specializing in anti-inflammatory therapeutics targeting the complement system, announced its participation in the Raymond James 2026 Biotech Innovation Symposium. The company will hold individual investor meetings during the event to discuss its ongoing programs, including its oral small molecule izicopan …
MiNK Therapeutics reported their Q4 and full-year 2025 financial results, highlighting significant progress in their iNKT cell therapy pipeline targeting severe immune-mediated diseases such as ARDS, pulmonary fibrosis, cancer, and GVHD. The company secured non-dilutive funding from collaborations and grants, advanced multiple clinical programs, an…
Legato Merger Corp. III disclosed that its audited financial statements contain a going concern explanatory paragraph by its independent auditors, as previously reported. The company reiterated no changes to its financial statements and highlighted the pending business combination with Einride AB, expected to close in the first half of 2026, which …
BOS Better Online Solutions Ltd. (BOSC) reported record revenue and net income for the full year 2025, driven by strong growth in its Supply Chain and Intelligent Robotics divisions despite continuing geopolitical tensions affecting its RFID division. The company projects stable revenue and net income for 2026, reflecting operational discipline and…
Palvella Therapeutics provided its full year 2025 financial results and updated on its clinical development programs. The company announced positive Phase 3 SELVA study results for QTORIN™ rapamycin for microcystic lymphatic malformations with plans to submit an NDA in the second half of 2026 and potential FDA approval in early 2027. Additional Pha…
Old National Bancorp, a leading Midwest-based commercial bank, announced its schedule for the first-quarter 2026 earnings release on April 22, followed by a conference call. The company offers a replay of the call on its investor relations website. With $72 billion in assets, Old National serves the Midwest and Southeast and provides commercial ban…
Friedman Industries, a Texas-based metals processing and pipe manufacturing company, announced a cash dividend of $0.04 per share to be paid on May 22, 2026. This marks the company's 217th consecutive quarterly dividend since going public in 1972, reflecting its commitment to returning value to shareholders. The Board reviews dividends quarterly, a…
Milestone Scientific Inc. reported modest revenue growth and significantly reduced operating losses in 2025, highlighting a strategic shift from restructuring to growth under new leadership. The company anticipates double-digit revenue growth in 2026, driven by a 400% increase in CompuFlo sales, expansion in dental and medical segments, and improve…
KULR Technology Group, Inc. reported its fourth quarter and full-year 2025 financial results, highlighting a 51% increase in full-year revenue driven by growth in product sales and expanded customer relationships. Despite revenue gains, the company posted a substantial net loss for the year, largely due to a $28 million mark-to-market bitcoin loss …
Alvotech, a biotechnology firm specializing in biosimilar medicines, has filed its 2025 Annual Report with the U.S. SEC. The report highlights the company's portfolio of approved biosimilars and an active pipeline targeting multiple therapeutic areas, supported by strategic global partnerships for market expansion.
Alvotech, a Nasdaq-listed biotechnology firm specializing in biosimilars, has published its 2025 Annual Report. The company continues its focus on developing and commercializing high-quality biosimilar medicines globally, with five biosimilars already approved and marketed. Their pipeline includes nine biosimilar candidates targeting multiple thera…
Curanex Pharmaceuticals reports significant progress in manufacturing, toxicology, intellectual property, and regulatory preparations for its lead drug candidate Phyto-N, targeting ulcerative colitis. The company completed GMP pilot batch production and pivotal toxicology studies, aiming for an IND submission by late 2026 and plans to initiate Phas…
Future Money Acquisition Corporation, a Cayman Islands-based blank check company, successfully completed its IPO by offering 11.2 million units at $10 each, including a partial exercise of the underwriters' overallotment option. The company raised gross proceeds of $112 million and concurrently closed a private placement for an additional $3 millio…
KPET Ultra Paceline Corporation, a blank check company sponsored by experienced investors Eduardo Tamraz and Karl Peterson, announced the pricing of its initial public offering of 20 million units priced at $10 each. The units will begin trading on the New York Stock Exchange under the ticker KPET.U on March 31, 2026. Each unit comprises one Class …
QDRO Acquisition Corp., a blank check company, completed its initial public offering of 20 million units at $10 per unit, raising $200 million. The units began trading on the Nasdaq under ticker QADRU. The company aims to identify potential business combinations in financial services, digital currency, and technology sectors.
Glucotrack, Inc. reported its 2025 financial results and significant corporate progress including the receipt of three new U.S. patents for its implantable continuous blood glucose monitoring (CBGM) technology, a $4 million private placement, and preparations to file for Investigational Device Exemption (IDE) with the FDA to launch U.S. clinical tr…
Oxbridge Re Holdings Limited reported strong financial results for 2025, highlighting outperforming tokenized reinsurance products and strategic platform expansion. The Balanced Yield Token surpassed its 20% annual return target, now estimated at 25%, and the High Yield Token remains on track for 42% returns. The company expanded its ecosystem thro…
Aptera Motors Corp. announced a GAAP net loss of $15.5 million for Q4 2025 and $43.9 million for the full year, alongside non-GAAP adjusted net losses of $8.7 million and $18.5 million respectively. The company raised $17.1 million in early 2026 to support production efforts and made progress on its validation assembly line and fleet assembly. Desp…
Bio Green Med Solution, Inc. (NASDAQ: BGMS) announced its Q4 and full-year 2025 financial results, highlighting a strategic shift from biopharmaceuticals to fire safety protection and distribution activities following the acquisition of Fitters Sdn. Bhd. The company completed the liquidation of its UK subsidiary and sold its drug candidate plogoser…
DeFi Development Corp. reported a remarkable 442% revenue increase for fiscal year 2025. The company attributes this growth to its unique treasury strategy focused on accumulating and compounding Solana (SOL) holdings, operational validator infrastructure generating staking rewards, and its AI-powered SaaS platform serving the commercial real estat…
Rocket Lab Corporation has obtained regulatory approval from Germany's Federal Ministry for Economic Affairs and Energy to acquire Mynaric AG, a leading provider of laser optical communications terminals for air, space, and mobile applications. The acquisition is expected to close in April 2026 and will enable Rocket Lab to expand its support of Ge…
BridgeBio Pharma reported compelling long-term data from its ATTRibute-CM open-label extension trial showing that acoramidis significantly reduces all-cause and cardiovascular mortality by approximately 45% and 49%, respectively, in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) through 54 months. The treatment also stabilize…
HII, America's largest shipbuilder, has signed a memorandum of understanding with GrayMatter Robotics to advance shipbuilding through Physical AI technology. This partnership aims to enhance manufacturing automation, increase throughput, and reduce rework in shipbuilding and related industries using cutting-edge AI robotics solutions developed by G…
FitLife Brands announced it will release its fourth quarter fiscal 2025 financial results on March 31, 2026, followed by an investor conference call on April 1, 2026. The company specializes in nutritional supplements and wellness products and distributes over 500 SKUs online and in retail.
